Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab175635-100μg
|
100μg |
10
|
$189.90
|
|
|
Ab175635-1mg
|
1mg |
4
|
$919.90
|
|
|
Ab175635-5mg
|
5mg |
1
|
$2,299.90
|
|
|
Ab175635-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$3,679.90
|
|
Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
| Product Name | Polatuzumab vedotin-piiq (anti-CD79b) - Primary antibody, specific to CD79B, >90% (SDS-PAGE&SEC), high purity, Human IgG1, Antibody of CD79B |
|---|---|
| Synonyms | AGM6 antibody | B cell antigen receptor complex associated protein beta chain antibody | B cell specific glycoprotein B29 antibody | B-cell antigen receptor complex-associated protein beta chain antibody | B-cell-specific glycoprotein B29 antibody | B29 a |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥90%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | CD79B |
| Conjugation | MC-VC-PAB-MMAE |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | ANTIBODY |
| Mechanism of action | Antibody of CD79B |
| Product Description |
Polatuzumab vedotin-piiq (anti-CD79b) is an antibody-drug conjugate targeting CD79b. It contains a humanized anti-CD79b IgG1 monoclonal antibody linked to monomethyl auristatin E (MMAE), a potent microtubule inhibitor. Polatuzumab vedotin-piiq (anti-CD79b) has the potential for the research of Large B-cell lymphomas (LBCL). |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 150.53 kDa |
| Purification Method | Protein A purified |
| Purity | >90% (SDS-PAGE&SEC) |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
| CAS | 1313206-42-6 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD79b with Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).
Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) - SEC
The purity of Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) is more than 95% verified by HPLC.
Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) - ELISA
Immobilized Recombinant Human CD79B protein (rp144109) at 1.0 μg/mL can bind Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) with the EC50 of 51.95 ng/mL.
Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD79b (red) with Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 21, 2024 | Ab175635 | |
| Certificate of Analysis | Jun 21, 2024 | Ab175635 | |
| Certificate of Analysis | Jun 21, 2024 | Ab175635 |